Personalised medicine for cancer: from molecular signature to therapeutic choice.

Article by Professor Karol Sikora


In the field of cancer medicine, great strides have been made in understanding the fundamental biology of cancers and impressive treatments have emerged resulting in markedly prolonged survival for many patients. These advances mean that cancer could well become a chronic disease within the next 20 years, but that promise depends on sustained investment in innovation in both diagnostics and therapies as well as society's willingness to pay for both.

view pdf